✦ LIBER ✦

Evaluation of efficacy and safety of FOLFIRI for elderly patients with gastric cancer: A first-line phase II study

✍ Scribed by Marianne Fonck; Réné Brunet; Yves Becouarn; Jean-Louis Legoux; Jérôme Dauba; Laurent Cany; Denis Smith; Dominique Auby; Éric Terrebonne; Laurent Traissac; Cécile Mertens; Pierre Soubeyran; Carine Bellera; Muriel Rainfray; Simone Mathoulin-Pélissier

Book ID: 119218462
Publisher: Elsevier
Year: 2011
Tongue: French
Weight: 297 KB
Volume: 35
Category: Article
ISSN: 2210-7401
DOI: 10.1016/j.clinre.2011.08.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

3046 POSTER A randomized, open-label pha

3046 POSTER A randomized, open-label phase II study evaluating the efficacy and safety of FOLFOX6 + Cetuximab versus FOLFIRI + Cetuximab as first-line therapy in patients with metastatic colorectal cancer

✍ T.E. Ciuleanu; W. Scheithauer; G. Kurteva; J. Ocvirk; I. Koza; D. Papamichael; M 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 55 KB

First-line sunitinib plus FOLFIRI in Jap

First-line sunitinib plus FOLFIRI in Japanese patients with unresectable/metastatic colorectal cancer: A phase II study

✍ Yasushi Tsuji; Taroh Satoh; Akihito Tsuji; Kei Muro; Motoki Yoshida; Tomohiro Ni 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 158 KB

A phase II study of modified FOLFOX as f

A phase II study of modified FOLFOX as first-line chemotherapy for metastatic gastric cancer in elderly patients with associated diseases

✍ Vincenzo Catalano, Renato Bisonni, Francesco Graziano, Paolo Giordani, Paolo Ale 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 240 KB

Safety and efficacy of first-line bevaci

Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study

✍ Van Cutsem, E.; Rivera, F.; Berry, S.; Kretzschmar, A.; Michael, M.; DiBartolome 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 201 KB

A retrospective observational study on t

A retrospective observational study on the safety and efficacy of first-line treatment with bevacizumab combined with FOLFIRI in metastatic colorectal cancer

✍ López, R; Salgado, M; Reboredo, M; Grande, C; Méndez, J C; Jorge, M; Romero, C; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 320 KB

Use of the folinic acid/5-fluorouracil/i

Use of the folinic acid/5-fluorouracil/irinotecan (FOLFIRI 1) regimen in elderly patients as a first-line treatment for metastatic colorectal cancer: a Phase II study

✍ Eric François; Jean-François Berdah; Emmanuel Chamorey; Gérard Lesbats; Eric Tei 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 286 KB